Cargando…

Bilateral interstitial keratitis following COVID-19: a case report

BACKGROUND: Although the primary target of severe acute respiratory syndrome coronavirus 2 is the respiratory tract, the expression of the angiotensin-converting enzyme 2 receptor in other tissues facilitates viral entry in others parts of the body, including ocular structures. Ocular manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales: Daher, Nathalie Dalloul, Syed, Zeba A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571384/
https://www.ncbi.nlm.nih.gov/pubmed/37833623
http://dx.doi.org/10.1186/s12886-023-03160-4
_version_ 1785119979710971904
author Daher, Nathalie Dalloul
Syed, Zeba A.
author_facet Daher, Nathalie Dalloul
Syed, Zeba A.
author_sort Daher, Nathalie Dalloul
collection PubMed
description BACKGROUND: Although the primary target of severe acute respiratory syndrome coronavirus 2 is the respiratory tract, the expression of the angiotensin-converting enzyme 2 receptor in other tissues facilitates viral entry in others parts of the body, including ocular structures. Ocular manifestations may occur before, during, or after systemic infection. CASE PRESENTATION: We report the case of a 60-year-old male who presented with bilateral interstitial keratitis after the onset of COVID-19, with ocular symptoms starting within 7 days after systemic symptoms. Laboratory investigation did not identify any alternative etiology for his disease, although the possibility of Epstein-Barr virus or herpes simpex virus could not be definitively ruled out. The patient had already developed significant corneal scarring and visual debilitation by the time topical steroids were initiated, and his final corrected visual acuity with rigid gas permeable contact lenses was 20/50 and 20/80 in the right and left eye, respectively. CONCLUSIONS: The involvement of ocular tissue by the virus can lead to permanent sequelae such as severe visual loss, and clinicians should be aware of and recognize ophthalmic manifestations of this disease to prompt early intervention.
format Online
Article
Text
id pubmed-10571384
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105713842023-10-14 Bilateral interstitial keratitis following COVID-19: a case report Daher, Nathalie Dalloul Syed, Zeba A. BMC Ophthalmol Case Report BACKGROUND: Although the primary target of severe acute respiratory syndrome coronavirus 2 is the respiratory tract, the expression of the angiotensin-converting enzyme 2 receptor in other tissues facilitates viral entry in others parts of the body, including ocular structures. Ocular manifestations may occur before, during, or after systemic infection. CASE PRESENTATION: We report the case of a 60-year-old male who presented with bilateral interstitial keratitis after the onset of COVID-19, with ocular symptoms starting within 7 days after systemic symptoms. Laboratory investigation did not identify any alternative etiology for his disease, although the possibility of Epstein-Barr virus or herpes simpex virus could not be definitively ruled out. The patient had already developed significant corneal scarring and visual debilitation by the time topical steroids were initiated, and his final corrected visual acuity with rigid gas permeable contact lenses was 20/50 and 20/80 in the right and left eye, respectively. CONCLUSIONS: The involvement of ocular tissue by the virus can lead to permanent sequelae such as severe visual loss, and clinicians should be aware of and recognize ophthalmic manifestations of this disease to prompt early intervention. BioMed Central 2023-10-13 /pmc/articles/PMC10571384/ /pubmed/37833623 http://dx.doi.org/10.1186/s12886-023-03160-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Daher, Nathalie Dalloul
Syed, Zeba A.
Bilateral interstitial keratitis following COVID-19: a case report
title Bilateral interstitial keratitis following COVID-19: a case report
title_full Bilateral interstitial keratitis following COVID-19: a case report
title_fullStr Bilateral interstitial keratitis following COVID-19: a case report
title_full_unstemmed Bilateral interstitial keratitis following COVID-19: a case report
title_short Bilateral interstitial keratitis following COVID-19: a case report
title_sort bilateral interstitial keratitis following covid-19: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571384/
https://www.ncbi.nlm.nih.gov/pubmed/37833623
http://dx.doi.org/10.1186/s12886-023-03160-4
work_keys_str_mv AT dahernathaliedalloul bilateralinterstitialkeratitisfollowingcovid19acasereport
AT syedzebaa bilateralinterstitialkeratitisfollowingcovid19acasereport